Before revision: As of January 2021, the phase II trial of the drink is complete and have shown positive results by 87.3%DIF < of the patients.No secondary effects were found during trials.madagascar-l-usine-pharmalagasy-lance-la-3e-déclinaison-du-covid-organics Phase III trials were published in January 2023 on CVO+ resulted in a signicantly higher rate of treatment successEfficacy and safety of CVO PLUS CURATIF capsules, Malagasy improved traditional medication for treating COVID-19 a randomized double blind placebo controlled trials.
After revision: Phase III trials were published in January 2023 on CVO+ resulted in a signicantly higher rate of treatment successEfficacy and safety of CVO PLUS CURATIF capsules, Malagasy improved traditional medication for treating COVID-19 a randomized double blind placebo controlled trials.